MILLENNIUM NEWSROOM
Category
Artificial intelligence is transforming healthcare by enabling earlier disease detection, improving clinical decision-making, streamlining hospital operations and supporting a more predictive, patient-centric model of care.
DeepFacts Pvt. Ltd. has announced plans to expand its AI-powered remote patient monitoring platform, proRITHM, across southern India before targeting nationwide growth by early 2027 and a U.S. market entry by late 2027 or early 2028.
Zydus Lifesciences has received approval to initiate a Phase III clinical trial of Desidustat for sickle cell disease in collaboration with ICMR, following encouraging Phase II results demonstrating efficacy and safety.
CBM India has brought together LGBTQIA+ community representatives, government officials and civil society organisations in Bengaluru to co-create Project Sparsh, an initiative aimed at improving health, livelihoods and social inclusion.
HRV Pharma has unveiled RIKO™, India’s first AI-native pharmaceutical operating system, designed to transform decision-making across sales, regulatory affairs, quality, manufacturing and supply networks through real-time operational intelligence.
CBM India highlighted the need for disability-inclusive eye health systems at the 20th VISION 2020: The Right to Sight – INDIA Annual Conference, showcasing research and scalable models for accessible eye care.
OneSource Specialty Pharma and Germany-based Formycon AG have entered a strategic manufacturing partnership to support global biosimilar programs through integrated biologics manufacturing capabilities.
Zydus Pinkathon is set to return to Chennai after seven years on August 1-2, bringing together thousands of women to celebrate fitness, promote preventive healthcare, and raise breast cancer awareness.
HCG Manavata Cancer Centre in Nashik successfully treated a Dubai-based prostate cancer patient with robotic-assisted surgery following a carefully coordinated treatment plan after cardiac surgery.
Aragen Life Sciences has become the first and only CRDMO in India to be recognized among Great Place to Work® India’s Top 100 Best Companies to Work For 2026, while retaining its position among the country's Top 25 workplaces in pharmaceuticals, healthcare and biotech for the fourth consecutive year.
On National Doctor's Day 2026, SSO Cancer Hospital urged greater focus on physician well-being, emphasizing that healthier doctors lead to safer, more compassionate, and higher-quality patient care.
CORONA Remedies has inaugurated and commercialised its dedicated EU-GMP approved hormone manufacturing facility in Ahmedabad, strengthening India's pharmaceutical manufacturing capabilities for women's healthcare.